The transcriptional profiles of related pathogens and their response to host 50 induced stresses underpin their pathogenicity. Expression differences between 51 related pathogens during host interaction can indicate when and how these 52 genes contribute to virulence, ultimately informing new and improved treatment 53 strategies for those diseases. In this paper, we compare the transcriptional 54 profiles of five isolates representing four lineages of C. gattii in rich media. Our 55 analyses identified key processes including cell capsule, ergosterol production 56 and melanin that are differentially expressed between lineages, and we find that 57 VGII has the most distinct profile in terms of numbers of differentially expressed 58 genes. All lineages have also undergone sub-functionalisation for various 59 paralogs including capsule biosynthesis and attachment genes. Most genes 60 appeared down-regulated during co-incubation with macrophages, with the 61 largest decrease observed for capsule attachment genes, which appears 62 coordinated with a stress response, as all lineages also upregulated oxidative 63 stress response genes. Furthermore, VGII upregulated many genes that are 64 linked to ergosterol biosynthesis and switched expression of the laccase LAC1 to 65 LAC2 ex vivo. Finally, we saw a pronounced increase in the FosB/Jun/Egr1 66 regulatory proteins at early time points in bone marrow derived macrophages, 67 marking a role in the host response to C. gattii. This work highlights the dynamic 68 roles of key C. gattii virulence genes in response to macrophages. 69 70 can cause pneumonia and meningoencephalitis in humans (5). While C. gattii 79 causes less overall global morbidity than its sibling species C. neoformans, 80 lineages have emerged with hypervirulent clinical phenotypes, a process that 81
Abstract 23
Cryptococcus gattii is a pathogenic yeast of humans and other animals, which 24 causes disease predominantly in immunocompetent hosts. Infection begins when 25 aerosolized yeast or spores enter the body, triggering an immune response, 26
including engulfment by macrophages. To understand the early transcriptional 27 signals in both the yeast and its mammalian host, we performed a time-course 28 dual RNA-seq experiment for four lineages of C. gattii (VGI-IV) interacting with 29 mouse macrophages at 1hr, 3hr and 6hr post infection. Comparison of in vitro to 30 ex vivo gene expression indicates lineage VGII is transcriptionally divergent to 31 non-VGII lineages, including differential expression of genes involved in capsule 32 synthesis, capsule attachment and ergosterol production. Various paralogs 33 demonstrate sub-functionalisation between lineages including an upregulation of 34 capsule biosynthesis-related gene CAP2, and downregulation of CAP1 in VGIII. 35
Isolates also compensate for lineage-specific gene-losses by over-expression of 36 genetically similar paralogs, including an over-expression of capsule gene CAS3 37 in VGIV having lost CAS31. Differential expression of one in five C. gattii genes 38 was detected following co-incubation with mouse macrophages; all isolates 39 showed high induction of oxidative-reduction functions and a downregulation of 40 capsule attachment genes. We also show that VGII switches expression of two 41 laccase paralogs (from LAC1 to LAC2) during co-incubation of macrophages. 42
Finally, we found that mouse macrophages respond to all four lineages of C. 43 gattii by upregulating FosB/Jun/Egr1 regulatory proteins at early time points. This 44 study highlights the evolutionary breadth of expression profiles amongst the 45 lineages of C. gattii and the diversity of transcriptional responses at this host-46 pathogen interface. 47
Introduction 71 72 Infectious diseases impose a huge burden on human society. In recent years, 73 fungi have gained widespread attention for their ability to threaten both animal 74 and plant species across a global scale (1, 2) . However, many features of the 75 fungal genome and transcriptome that enable the infection of diverse hosts and 76 ecological niches remain largely unexplored, especially for emerging pathogens 77
(3, 4). One such example is the basidiomycete yeast Cryptococcus gattii, which 78 expression in mouse macrophages clustered by time point (Fig. 1b) . 146 147 Differential expression was computed using the quantile-adjusted conditional 148 maximum likelihood (qCML) method implemented in EdgeR (17), requiring a 149 false discovery rate (FDR) p-value <1e -3 and at least fourfold change in Trimmed 150
Mean of M-values (TMM) normalized Fragments Per Kilobase of transcript per 151
Million Mapped reads (FPKM), to be considered as a significantly differentially 152 expressed gene (DEG). To check for the effect of different read-depths on DEG 153 prediction, subsets were created and re-analysed. This analysis identified 154 consistent numbers of DEGs in vitro, and more variable numbers between 155 infection time-points ( Fig. S4) . 156 7 uniquely differentially regulated among the four divergent lineages, despite being 162 all cultured in the same rich media at 37°C with 5% CO 2 ( Fig. 2a, Fig. 2e , Sup. 163
Dataset 1). A G-test of goodness-of-fit based on just the numbers of in vitro 164
DEGs per lineage (not considering specific genes) suggested differences (G = 165 328.52, X-squared df = 4, p-value < 2.2e -16 ), and pairwise comparisons using G-166 tests with Bonferroni multiple correction also showed differences between VGII 167 isolates compared with VGI, VGII ENV152 and VGIV, but not VGII R265 (p-value 168 < 2.2e -16 ). VGIV compared with VGI or VGIII were also highly distinct for 169 numbers of DEGs (p-value < 2.2e -16 ). 170
171
Of the 524 in vitro DEGs, 203 were differentially regulated in both VGII isolates, 172 245 additional genes were differentially regulated for only an individual VGII 173 isolate, and 50 were differentially regulated inconsistently across VGII (e.g. 174 upregulated in VGIV vs VGII R265 and upregulated in VGI vs both VGII isolates). 175
While some of these genes were also differentially expressed in other lineages, 176 only 5% (n=27) of in vitro DEGs were unique to VGI, VGIII or VGIV isolates, 177
suggesting VGII harbors distinct expression profiles compared with the other 178 lineages. Furthermore, the greater number of genes uniquely differentially 179 expressed within isolates of the VGII isolates suggests that substantial 180 differences exist even within the VGIIa sub-lineage, possibly owing to genetic 181 variation generated from their different sources of origin (environmental or 182 clinical). Furthermore, VGII isolates were distinct by Principle Component 183 Analysis (PCA) ( Fig. 2c) , while VGI and VGIV were not. 184
185
To understand the role that differential expression may have on each isolate in 186 vitro, we opted for both a targeted approach (looking at known genes of interest 187 including 35 capsule biosynthesis genes, 40 capsule attachment and cell-wall 188 remodelling genes and 20 ergosterol genes (18) based on their orthology to C. 189 neoformans H99 (7)) and a non-targeted approach (GO-term and PFAM 190 enrichment). Of the 524 unique DEGs, 8/35 were involved in capsule 191 biosynthesis, 10/40 in capsule attachment and cell-wall remodelling, 4/20 in 192 ergosterol production, and both laccase genes were differentially expressed in at 193 least one pairwise comparison (Fig. 3) . These gene categories are therefore 194 enriched for DEGs based on a Hypergeometic Test (P[X > x]) = P=1.207e -07 ). 195
196
In vitro C. gattii lineages have distinct expression for capsule biosynthesis 197 and attachment genes 198
Capsule biosynthesis genes were differentially expressed between lineages in 199 vitro (Fig. 3) 
Differential expression of known drug targets and virulence genes 230
In common with most fungi, ergosterol is found in the membrane of C. gattii and Fisher's exact test with q-value FDR) for several GO-terms compared with the 258 remaining genes ( Table 1) were upregulated in vitro vs. ex vivo (Fig. 2b, Sup. Dataset 2). About 1/3 282 (n=309) of these genes were also differentially expressed in an inter-lineage in 283 vitro comparison (60% of them), leaving 215 genes that were uniquely 284 differentially expressed in vitro. PCA showed large differences between t0 and ex 285 vivo time points in both VGII isolates ( Fig. 2d) . 286
287
Genes of interest (capsule, ergosterol and laccases) were enriched for DEGs at 288 different time points based on a Hypergeometic Test (P[X > x]) = P=0.007), 289
including nine capsule biosynthesis genes (all VGII), 11 capsule attachment and 290 cell-wall remodelling genes (all downregulated ex vivo), 14 ergosterol genes and 291 both laccase genes ( Fig. 4) . Separately, many (n=40/97; 41%) C. neoformans 292 genes that were previously found to be differentially expressed via microarray in 293 the presence of amoebae and macrophages (13) were similarly modulated in C. 294 gattii (111 genes with similar or different modulation between amoeba and 295 macrophages, 97 of which had a C. gattii ortholog, 56 of which were also C. gattii 296
DEGs between time points, and 40 had the same directionality) (Sup. Dataset 297
3). 298 299
Genes differentially expressed ex vivo were statistically significantly enriched 300 (two-tailed Fisher's exact test with q-value FDR) for 18 GO-terms and no PFAM 301 terms ( Table 1) . Strikingly, the oxidoreductase activity term was enriched in each 302 lineage and isolate (apart from VGIV which had only 20 differentially expressed 303 genes and thus no enriched terms). The ability for C. gattii to respond to host and 304 environment derived oxidative stress is thus a significant feature of genes 305 differentially expressed (both between lineages in vitro, and between in vitro and 306 ex vivo conditions). Additional terms included Iron-ion binding and terms related 307 to ribosomes (i.e. rRNA processing, structural constituent of ribosome) for VGII 308 ENV152, perhaps indicating an increase in translational activity. 309 310 Capsule biosynthesis genes in VGII were differentially expressed in the presence 311 of macrophages ( Fig. 4) . For example, CAP1 and UGT1 are downregulated by 312 both VGII isolates, while CAP4, CAS3 and UGD1 are all upregulated at one or 313 more of the ex vivo timepoints. Other capsule biosynthesis DEGs included 314 CAS35 (CAS35 has a decreased capsule (19)) upregulated in R265 at t3 vs t0, 315 UXS1 (uxs1 capsule is missing xylose (28)) upregulated in R265 at t1 and t3 vs 316 t0, and CAS1 (cas1 has a defect in capsule O-acetylation and reactivity to GXM 317 antibodies (29)) is upregulated in VGII ENV152 at t3. That non-VGII lineages did 318 not differentially express capsule synthesis genes ex vivo may suggest that they 319 are less rigorously regulated (expressed in more conditions), expressed less 320 abundantly, or are perhaps less sensitive to host-derived stresses and stimuli. 321
322
Capsule attachment and cell-wall remodelling genes were also differentially 323 expressed ex vivo, predominantly by VGII isolates, and were all downregulated 324 ex vivo (Fig. 4) . For example, the chitin synthases CHS4 and CHS8 were 325 The four ergosterol genes CNBG0583/CNAG01003, ERF1, SRE1 and ERG25 333 that are upregulated in VGII compared with VGIII and VGIV in vitro were also 334 upregulated in VGII in vitro compared with the three ex vivo time points, again 335 suggesting these are downregulated during infection. However, nine additional 336 ergosterol biosynthesis genes including ERG2, ERG6, ERG7, ERG13, ERG20 337 and ERG26 were each upregulated in the VGII isolates at three hours post 338 infection compared with in vitro, suggesting these genes are activated >1 hour 339 and <6 hours following co-incubation with macrophages. 340
341
The laccase genes that produce melanin and are upregulated in VGIV in vitro 342 compared with the other lineages, are also differentially expressed in VGII 343 between in vitro and ex vivo conditions. Specifically, LAC1 (CNBG2144) in VGI 344 and VGII is downregulated ex vivo. In contrast, LAC2 (CNB2146) is upregulated 345 in both VGII isolates at t3 compared with t0demonstrating that during infection, 346 13 VGII isolates switch expression from LAC1 to LAC2, perhaps owing to LAC2's 347 ability to remain cytoplasmic (31). the primary growth factor response. Perhaps it is therefore unsurprising that 20% 365 suggesting these genes can be switched off during non-drug related stresses. 438
However, a further nine ergosterol genes were upregulated between 1 and 6 439 hours post infection, including ERG2, ERG6, ERG7, ERG13, ERG20 and 440 ERG26, suggesting that this pathway is active during infection. 441
442
Laccase production (LAC1 and LAC2) in both C. gattii and C. neoformans is 443 controlled by two cell wall enzymes that possesses a broad spectrum of activity 444 oxidizing both polyphenolic compounds and iron (25). VGIV upregulates both 445 genes compared with other lineages in vitro. LAC1 is downregulated in VGI and 446 VGII ex vivo compared with in vitro, and instead LAC2 is upregulated in both 447 VGII isolates at t3 compared with t0suggesting that C. gattii VGII switches 448 expression from one laccase gene to the other during infection, perhaps due to 449 changing concentrations or requirements for metabolism of lactose and 450 galactose, or production of melanin. In C. neoformans, LAC1 and LAC2 (along 451 with capsule genes) are part of the Gpa1-cAMP pathway, which regulates 452 capsule and melanin production using L-dopa as a substrate (37). We 453 hypothesise that VGII uses LAC2 to regulate growth and glucose responses (and 454 potentially virulence) instead of LAC1. In C. neoformans, LAC1 is localised to the 455 cell wall, whereas LAC2 is cytoplasmic, but is capable of localising to the cell wall 456 (31); therefore, C. gattii LAC2 could behave similarly to its C. neoformans 457 counterpart, which may have increased versatility during infection of 458
macrophages. 459 460
We also identified differential expression in VGII lineage-specific genes such as 461 an MFS transporter and an oxidoreductase that may have contributed to the 462 enrichment of 'oxidative reduction', which was identified in both in vitro 463 comparisons and in vitro vs ex vivo comparisons. This term includes a wide-464 range of functions, pathways, and genes including ferric reductases, 465 metalloreductases, nitric oxide dioxygenases, acidic laccases, oxidoreductases 466 and various dehydrogenases. Previously, an upregulation of genes involved in 467 oxidative stress has been identified in C. neoformans isolate H99 co-incubated 468 with J774A macrophage-like cell line for 16 hours vs in vitro conditions (12) , and 469 in C. gattii VGII isolates R265 vs R272 in carbon and nitrogen starvation (16). 470
The ability for C. gattii to respond to host and environment derived oxidative 471 stress is well describedand it is consistent that genes involved in these 472 processes should also be enriched between isolates and lineages at the 473 expression level in vitro and among lineages at different time points ex vivo. 474 475 Finally, we found that mouse macrophages respond to C. gattii by upregulating 476 FosB/Jun/Egr1 regulatory proteins at early time points, which may trigger 477 differentiation and cell division of macrophages. We found little evidence for 478 differential expression induced by different C. gattii lineages suggesting that the 479 macrophage response to C. gattii is the same across lineages. Our study 480 highlights the breadth of expression profiles amongst the lineages of C. gattii, 481 and the diversity of transcriptional responses at this host-pathogen interface, 482 some of which may be the cause for differences in phenotypic and clinical 483 manifestations noted between lineages (38). (combining t1, t3, t6) , and in 564 vitro (combining each isolate at t0). (a) The total number of differentially 565 expressed genes changes (either going up or down) for isolates ex vivo, but not 566 in vitro. (b) The percent of genes found in the full dataset (i.e. a proxy for true 567 positives). >75% for all categories using 75% subsets, >50% for all categories 568 using 50% subsets, and >25% for all categories using 25% subsets. (c) The 569 number of genes found only in the full dataset (i.e. a proxy for false negatives). 570 VGI, VGIII and VGIV re-identified most of the genes also found with their full 571 datasets, while VGII and in vitro conditions recovered fewer genes found in the 572 full dataset as the subset becomes smaller. Macrophage and Cryptococcus gattii infection assay. 616 C. gattii was grown in accordance with previous work(26). Briefly, five strains of 617 C. gattii were grown in RPMI/C10 w/HI fetal bovine serum (FBS) media, and pre-618 incubated at 37°C in C10 media for 1.5hrs before infection. Bone marrow derived 619 macrophages (BMDM) were derived from bone marrow cells collected from the 620 femur and tibia of C57BL/6 female mice. All mouse work was performed in 621 accordance with the Institutional Animal Care and Use Committees (IACUC) and 622 with relevant guidelines at the Broad Institute and Massachusetts Institute of 623 Technology, with protocol 0615-058-1. Primary bone marrow cells were grown in 624 "C10" media as previously described 42 and supplemented with macrophage 625 colony stimulating factor (M-CSF) (ThermoFisher Scientific) at final concentration 626 of 10 ng/ml to promote differentiation into macrophages. 627
628
For the infection experiment, dilutions of 7.5E+5 cells were made for BMDM and 629 C. gattii strains. BMDM were spun at 500rcf at 37°C for 2 minutes to adhere to 630 plates, and inoculated with C. gattii strains using a multiplicity of infection (MOI) 631 of 1 macrophage to 2 C. gattii. Macrophages with C. gattii cells were centrifuged 632 at 500rcf at 37°C for 2 minutes. Next, cells were incubated at 37°C with 5% CO 2 633 for 1hr, 3hr and 6hr post centrifuge. In addition, we grew C. gattii in vitro, and 634 BMDM without C. gattii, in duplicate with the same C10 media. At the end of the 635 time points, the media was removed, a lysis buffer added, and placed in a -70°C 636 freezer for RNA extraction. 637
638
RNA was extracted from population samples using the Qiagen RNeasy mini kit. 639
All samples were subjected to 3 minutes of bead beating with .5mm zirconia 640 glass beads (BioSpec Products) in a bead mill. Libraries were generated with the 641 sensitivity of our C. gattii RNAseq data and pipeline, we first made subsets (75%, 708 50% and 25%) of our C. gattii data and re-called differential expression ( Fig. S3) . 709
The number of genes differentially expressed between isolates in vitro conditions 710 remained most consistent in terms of number of differentially expressed genes 711 following sub-setting (100% = 1,208, 75%=1,205, 50%=1,147, 25%=800) ( Fig.  712   S3A) . 713 714 For all C. gattii datasets (those from in vitro conditions, and individual isolates 715 between conditions), the number of genes re-identified in the 75% subset was 716 between 79%-100% (VGIV CBS10101 had the same 20 genes in both Dataset 717 sizes) ( Fig. S3B) . Conversely, the number of genes identified only in the full 718 datasets increased in the remaining subsets, with the most pronounced being 719
VGIIa ENV152 losing the identification of 476 genes in the 75% subset, possibly 720 indicating a lack of data for this isolate (Fig. S3C) . We also assessed each 721 subset for genes that were not found in the full set (i.e. were unique to the 722 subsets, Fig. S3D ). VGII, VGIV and the in vitro datasets had fewer unique genes 723 as subsets became smaller, while VGI and VGIII had an increase as subsets 724 became smaller. 725
726
For in vitro conditions, between 10%-15% of genes were unique in their subsets, 727 while for VGII ENV152, it was between 1%-5%. For isolates with very few 728 identified differentially expressed genes (such as VGIV CBS10101 and VGIII 729 CA1873), the numbers of unique genes approached or even exceeded the 730 number found in the full dataset. Given this variation, it is therefore likely that 731 most of the ex vivo C. gattii datasets would benefit from deeper RNAseq data, 732 and that the in vitro expression values are more robust than ex vivo data. 733
Nevertheless, the majority of differential expressed genes were consistent 734 between the larger subsets of data 735 27 7. Farrer 
